Elevance Health
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
9% more call options, than puts
Call options by funds: $677M | Put options by funds: $619M
0.17% more ownership
Funds ownership: 88.63% [Q3] → 88.8% (+0.17%) [Q4]
6% less funds holding
Funds holding: 1,665 [Q3] → 1,559 (-106) [Q4]
25% less first-time investments, than exits
New positions opened: 207 | Existing positions closed: 276
26% less funds holding in top 10
Funds holding in top 10: 50 [Q3] → 37 (-13) [Q4]
29% less capital invested
Capital invested by funds: $106B [Q3] → $75.9B (-$30.3B) [Q4]
36% less repeat investments, than reductions
Existing positions increased: 462 | Existing positions reduced: 720
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$405
6%
downside
Avg. target
$472
9%
upside
High target
$512
18%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Argus Research David Toung 50% 1-year accuracy 6 / 12 met price target | 6%downside $405 | Hold Reiterated | 29 Jan 2025 |
Wells Fargo Stephen Baxter 32% 1-year accuracy 12 / 37 met price target | 10%upside $478 | Overweight Maintained | 28 Jan 2025 |
Cantor Fitzgerald Sarah James 35% 1-year accuracy 39 / 113 met price target | 12%upside $485 | Overweight Reiterated | 24 Jan 2025 |
Barclays Andrew Mok 41% 1-year accuracy 24 / 58 met price target | 18%upside $512 | Overweight Maintained | 24 Jan 2025 |
Truist Securities David Macdonald 62% 1-year accuracy 58 / 93 met price target | 11%upside $480 | Buy Maintained | 6 Jan 2025 |
Financial journalist opinion
Based on 7 articles about ELV published over the past 30 days
Positive
Zacks Investment Research
5 hours ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Neutral
Business Wire
23 hours ago
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code - 3972058 (Domestic) 312-470-0178 – Access Code - 3972058 (International) 800-39.
Positive
MarketBeat
1 day ago
Which Healthcare Stock Is the Best Buy Right Now?
In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an extended period of time before becoming profitable, but when they see success with a new product—or even clinical trial results suggesting a new product could be on the horizon—they can experience huge rallies in a very short period of time.
Positive
Zacks Investment Research
2 weeks ago
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
With a strengthening commercial business, ELV is seeing steady membership growth.
Positive
Seeking Alpha
2 weeks ago
Elevance Health: Add A Little Bit Of Health To Your Defensive Portfolio
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.
Positive
Zacks Investment Research
2 weeks ago
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Positive
Seeking Alpha
3 weeks ago
54 Upcoming Dividend Increases, Including A King
This week features the largest list of dividend increases ever, with 50 companies, including Coca-Cola extending its 63-year streak with a 5.2% increase. My strategy focuses on companies with consistent dividend growth and outperforming benchmarks, using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ. I recommend the Schwab U.S. Dividend Equity ETF for broad U.S. equity exposure and the Cohen & Steers REIT & Preferred Income Fund for REITs.
Positive
Seeking Alpha
1 month ago
Maximizing Returns: 3 Compelling Reasons To Invest In Elevance Health Now
Due to heightened political uncertainty, health insurer and pharmacy benefit manager, Elevance Health, continues to be shunned by the market. While I focused on the challenges and risks in my last article, in this update, I give three reasons why I feel comfortable taking a contrarian position with ELV stock. Given that Elevance is in financially very healthy shape and is strongly profitable, there is obviously a large margin of safety from an operational perspective.
Negative
Seeking Alpha
1 month ago
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact profits.
Positive
Seeking Alpha
1 month ago
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
Charts implemented using Lightweight Charts™